{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:54:23Z","timestamp":1785851663526,"version":"3.56.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9,27]]},"DOI":"10.1097\/01.tp.0000136988.38919.fb","type":"journal-article","created":{"date-parts":[[2004,9,20]],"date-time":"2004-09-20T04:07:41Z","timestamp":1095653261000},"page":"911-918","source":"Crossref","is-referenced-by-count":29,"title":["Impact of Thrombophilic Gene Mutations and Graft-versus-Host Disease on Thromboembolic Complications after Allogeneic Hematopoietic Stem-Cell Transplantation"],"prefix":"10.1097","volume":"78","author":[{"given":"Markus","family":"Pihusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Reitberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Andreesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Jochem","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Holler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Pihusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"9","key":"R1-19-20210129","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","article-title":"Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.","volume":"74","author":"Pihusch","year":"2002","journal-title":"Transplantation"},{"issue":"6","key":"R2-19-20210129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1703663","article-title":"Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation.","volume":"30","author":"Pihusch","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"6475","key":"R3-19-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C.","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"issue":"5","key":"R4-19-20210129","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V90.5.1747","article-title":"A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.","volume":"90","author":"Rosendaal","year":"1997","journal-title":"Blood"},{"issue":"5","key":"R5-19-20210129","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0038-1656059","article-title":"The mutation Ala677\u2013>Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.","volume":"77","author":"Arruda","year":"1997","journal-title":"Thromb Haemost"},{"issue":"5","key":"R6-19-20210129","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V95.5.1517.005k48_1517_1532","article-title":"Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.","volume":"95","author":"Lane","year":"2000","journal-title":"Blood"},{"issue":"1","key":"R7-19-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9149(98)00235-5","article-title":"PIa1\/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty.","volume":"82","author":"Mamotte","year":"1998","journal-title":"Am J Cardiol"},{"issue":"1","key":"R8-19-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.ATV.15.1.96","article-title":"European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction.","volume":"15","author":"Humphries","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"R9-19-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V98.1.231","article-title":"Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism.","volume":"98","author":"Ulrich","year":"2001","journal-title":"Blood"},{"issue":"7","key":"R10-19-20210129","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood.V98.7.2283","article-title":"Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification.","volume":"98","author":"Matsuo","year":"2001","journal-title":"Blood"},{"issue":"6","key":"R11-19-20210129","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation.","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"issue":"7","key":"R12-19-20210129","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation.","volume":"73","author":"Holler","year":"1989","journal-title":"Blood"},{"key":"R13-19-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1600-065X.1985.tb01160.x","article-title":"Graft-versus-host disease in dog and man: the Seattle experience.","volume":"88","author":"Storb","year":"1985","journal-title":"Immunol Rev"},{"issue":"2","key":"R14-19-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1096-8652(199806)58:2<150::AID-AJH13>3.0.CO;2-F","article-title":"Factor V Leiden mutation does not account for central venous catheter-related thrombosis.","volume":"58","author":"Riordan","year":"1998","journal-title":"Am J Hematol"},{"issue":"6","key":"R15-19-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1055\/s-0037-1615395","article-title":"4G\/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.","volume":"80","author":"Sartori","year":"1998","journal-title":"Thromb Haemost"},{"issue":"1","key":"R16-19-20210129","first-page":"1","article-title":"Subclavian vein thrombosis: a continuing challenge.","volume":"108","author":"Hill","year":"1990","journal-title":"Surgery"},{"issue":"1","key":"R17-19-20210129","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide.","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood"},{"issue":"6","key":"R18-19-20210129","first-page":"1097","article-title":"Endothelial-cell injury in cutaneous acute graft-versus-host disease.","volume":"135","author":"Dumler","year":"1989","journal-title":"Am J Pathol"},{"issue":"4","key":"R19-19-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"issue":"6","key":"R20-19-20210129","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V89.6.1931","article-title":"Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines.","volume":"89","author":"Lindner","year":"1997","journal-title":"Blood"},{"issue":"3","key":"R21-19-20210129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1084\/jem.163.3.740","article-title":"Modulation of endothelial cell hemostatic properties by tumor necrosis factor.","volume":"163","author":"Nawroth","year":"1986","journal-title":"J Exp Med"},{"issue":"2","key":"R22-19-20210129","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.168.2.751","article-title":"Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor\/cachectin-responsive genes.","volume":"168","author":"Medcalf","year":"1988","journal-title":"J Exp Med"},{"issue":"10","key":"R23-19-20210129","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"issue":"5","key":"R24-19-20210129","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"key":"R25-19-20210129","first-page":"75","article-title":"Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.","volume":"17","author":"Rozman","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"R26-19-20210129","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"issue":"6","key":"R27-19-20210129","first-page":"1029","article-title":"The 4G\/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis.","volume":"80","author":"Iacoviello","year":"1998","journal-title":"Thromb Haemost"},{"issue":"3","key":"R28-19-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ijc.10847","article-title":"Effect of methylenetetrahydrofolate reductase 677C\u2013>T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.","volume":"103","author":"Toffoli","year":"2003","journal-title":"Int J Cancer"},{"issue":"5","key":"R29-19-20210129","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/ajkd.2001.28602","article-title":"Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene.","volume":"38","author":"Fischereder","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200409270-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:29:00Z","timestamp":1785850140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200409270-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,27]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000136988.38919.fb","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9,27]]}}}